Pas de connexion internet — affichage de la version enregistrée de la page.

Revvity Inc.

USUSD
← Vers le screener

Revvity Inc. (US:RVTY) — Biotechnology: Laboratory Analytical Instruments. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 3. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site web
revvity.com
Secteur
Industrials · Biotechnology: Laboratory Analytical Instruments
Siège social
Waltham, United States
PDG
Prahlad R. Singh
Employés
11 000
Actions en circulation
111.59 M au 2026-08-06
Flottant
102.49 M
Capitalisation boursière
16.63 Md USD
Initiés
0.26%
Investisseurs institutionnels
96.55%
Secteur d'activité (SIC)
Laboratory Analytical Instruments
LEI
549300IKL1SDPFI7N655
Taux de distribution
13.4%
FCF
558 M USD
6%
Dette
3.21 Md USD
3.9 ans de FCF
Ancienneté du dividende
43 ans
Bénéfices, FCF et dividendes versés — pour les 12 mois précédant 05.07.2026 (le dernier rapport de l'entreprise).
Description

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Bourses et tickers

BourseTickerDevisePrixType
US USA StocksRVTY principaleUSD152.16 -0.94%actions ordinaires
LSE London Stock Exchange0KHE IOBUSD151.34 +0.00%actions ordinaires
XETRA XetraPKN secondaireEUR136.5 +0.18%actions ordinaires

Cours sur 3 mois

jour de hausse jour de baisse date de détachement du dividende date de versementSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Dividendes

Prochaine date ex : 2026-10-23 · 0.07 USD (US:RVTY)
12 derniers mois, US:RVTY: 0.28 USD (4 vers.)

Revvity Inc. (RVTY) verse des dividendes trimestriels. Au cours des 12 derniers mois, 0.28 USD par action ont été versés (versements : 4). Cela représente environ 0.18% du cours actuel de l'action. La prochaine date ex-dividende est le 23.10.2026 : 0.07 USD par action, versement le 13.11.2026. Historique des dividendes ininterrompu : 43 ans.

Date exVersementMontant%TypeTicker
2026-10-23 annoncé2026-11-130.0700 USD0.0/0.2 %trimestrielUS:RVTY
2026-07-172026-08-070.0700 USD0.0/0.2 %trimestrielUS:RVTY
2026-04-172026-05-080.0700 USD0.0/0.2 %trimestrielUS:RVTY
2026-01-162026-02-060.0700 USD0.0/0.2 %trimestrielUS:RVTY
2025-10-172025-11-070.0700 USD0.0/0.2 %trimestrielUS:RVTY
2025-07-182025-08-080.0700 USD0.0/≈0.2 %trimestrielUS:RVTY
2025-04-172025-05-090.0700 USD0.0/≈0.2 %trimestrielUS:RVTY
2025-01-172025-02-070.0700 USD0.0/≈0.2 %trimestrielUS:RVTY

Actualités de cette semaine

Communiqués de presse du site de l'entreprise pour les investisseurs, mis à jour chaque jour. Les liens mènent au site de l'entreprise. Les titres sont dans la langue originale, comme sur le site web de l'entreprise.

publicité

Principaux actionnaires

DétenteurParticipationActionsDate du rapport
T. Rowe Price Investment…16.37%18.26 M2026-06-30
T. ROWE PRICE CAPITAL AP…10.2%11.38 M2026-06-30
Jupiter Topco LLC7.74%8.64 M2026-06-30
Edgepoint Investment Gro…7.66%8.54 M2026-06-30
Blackrock Inc.6.86%7.66 M2026-06-30
Vanguard Capital Managem…6.54%7.3 M2026-06-30
JANUS INVESTMENT FUND-Ja…5.15%5.75 M2026-06-30
Price (T.Rowe) Associate…4.96%5.53 M2026-06-30
Vanguard Portfolio Manag…4.28%4.77 M2026-06-30
State Street Corporation3.89%4.34 M2026-06-30
Victory Capital Manageme…3.27%3.65 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%3.55 M2026-06-30
Dimensional Fund Advisor…3.07%3.43 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%2.89 M2026-06-30
-Price (T.Rowe) U.S. Val…2.41%2.69 M2026-06-30
TR PRICE-Price (T.Rowe)…2.41%2.69 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.29%2.56 M2026-06-30
JNL Series Trust-JNL/T.…2.27%2.53 M2026-06-30
Victory Portfolios-Victo…2.12%2.37 M2026-06-30
T. Rowe Price Value Fund…1.93%2.16 M2026-06-30
Invesco Exchange-Traded…1.67%1.87 M2026-08-31
SINGH PRAHLAD R (Chief E…≈0.09%105 6762026-08-13
GOLDBERG JOEL S (General…≈0.09%105 2232026-08-14
BARRETT PETER (Director)≈0.03%28 2932026-05-07
WITNEY FRANKLIN R. PH.D.…≈0.02%23 3542026-05-07
CHAPIN SAMUEL R. (Direct…≈0.02%22 6762026-05-07
VICTOR MIRIAME (Officer)≈0.02%18 1222026-02-24
WITZ PASCALE (Director)≈0.01%15 9852026-05-07
KRAKOWIAK MAXWELL (Chief…≈0.01%14 7812026-09-21
MICHAS ALEXANDROS P (Dir…——2026-08-25
MICHAS ALEXIS P (Directo…——2025-08-27